Yuan X, Guo X, Zhang J, Dong X, et al. Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: results from the LixiLan-L-CN randomize Diabetes Obes Metab 2022 Jun 28. doi: 10.1111/dom.14803.
PMID: 35762489